SPINET: A randomized, double-blind, placebo-controlled phase III study of lanreotide autogel/depot (LAN) in patients with advanced lung neuroendocrine tumors Meeting Abstract


Authors: Reidy-Lagunes, D.; Kulke, M.; Wolin, E.; Singh, S.; Ferone, D.; Mirakhur, B.; Hoffmanns, P.; Houchard, A.; Caplin, M.; Baudin, E.
Abstract Title: SPINET: A randomized, double-blind, placebo-controlled phase III study of lanreotide autogel/depot (LAN) in patients with advanced lung neuroendocrine tumors
Meeting Title: 9th Annual Meeting of the North American NeuroEndocrine Tumor Society (NANETS)
Journal Title: Pancreas
Volume: 46
Issue: 3
Meeting Dates: 2016 Sep 29-Oct 1
Meeting Location: Jackson Hole, WY
ISSN: 0885-3177
Publisher: Lippincott Williams & Wilkins  
Date Published: 2017-03-01
Start Page: 451
Language: English
ACCESSION: WOS:000394448600114
PROVIDER: wos
DOI: 10.1097/MPA.0000000000000812
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Diane Lauren Reidy
    294 Reidy